Virios Therapeutics (VIRI) Misses Q1 EPS by 2c

Virios Therapeutics (NASDAQ: VIRI) reported Q1 EPS of ($0.07), $0.02 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Workday shares slide 5% as revenue outlook offers little upside surprise
• Workday (WDAY) Tops Q2 EPS by 14c; offers outlook